Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of Schizophrenia
Clinical trial NCT02932605 · COMPLETED
Trial details
- NCT number
- NCT02932605
- Sponsor
- UMC Utrecht
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-03
- Primary completion
- 2020-01-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.